Dexiu Bu - Concepedia

Author

Dexiu Bu

Also Known As

Bu De-xiu, D. Bu, De-Xiu Bu, De-xiu Bu, Dexiu BU, Dexiu Bu, Doi Bu

Publications

301

Citations

H-Index

Concepts

All Affiliations

Dexiu Bu is an author at Novartis (United States) specializing in t cell immunity, medicine, and tumor immunity.

#	Concept	H-Index	Publications	Citations
1	Medicine	1	1	34
2	Cellular Therapies	1	1	34
3	Immunology	1	1	34
4	Hematology	1	1	34
5	Immunotherapy	1	1	34

Dexiu Bu

Publications

195

Citations

H-Index

Page 1

	Year	Citations
Pre-clinical validation of B cell maturation antigen (BCMA) as a target for T cell immunotherapy of multiple myeloma Dexiu Bu, Reshma Singh, Eugene Choi, Oncotarget	2018	70
Anti-BCMA/CD19 CAR T Cells with Early Immunomodulatory Maintenance for Multiple Myeloma Responding to Initial or Later-Line Therapy Alfred L. Garfall, Adam D. Cohen, Sandra P. Susanibar-Adaniya, Blood Cancer Discovery	2022	69
Updated phase I study results of PHE885, a T-Charge manufactured BCMA-directed CAR-T cell therapy, for patients (pts) with r/r multiple myeloma (RRMM). Adam S. Sperling, Benjamin A. Derman, Sarah Nikiforow, Journal of Clinical Oncology Hematological MalignancyCar T CellsTranslational MedicineCell TherapyR/r Multiple Myeloma	2023	34
Phase I Study of PHE885, a Fully Human BCMA-Directed CAR-T Cell Therapy for Relapsed/Refractory Multiple Myeloma Manufactured in &lt;2 Days Using the T-Charge TM Platform Adam S. Sperling, Sarah Nikiforow, Omar Nadeem, Blood	2021	22

Page 1